Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Altiva Management is a U.S.-based private investment adviser and private equity firm rather than an operating biotechnology, pharmaceutical, or healthcare product company. Public web records and business database listings identify it as a Nevada corporation formed in 2017, with activity tied to investment management and activist/investment holdings disclosures. Some investment-profile sources also connect the broader Altiva/Altiva Capital name to backing high-growth healthcare companies, but Altiva Management itself does not appear to develop therapeutics, diagnostics, or medical products directly. As a result, it should not be classified as a life sciences operating company and does not have a conventional drug pipeline, clinical stage, or therapeutic platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Altiva Management.